Femme et Homme
- | Pays :
- Italy
- Belgium
- United States
- Les 2 autres...
- | Organes : -
- | Spécialités : -
Extrait
The main purpose of this first in human study with CC-122 is to assess the safety and action of a new class of experimental drug (Pleiotropic Pathway Modulator) in patients with advanced tumors unresponsive to standard therapies and to determine the appropriate dosing level and regimen for later-stage clinical trials.
Critère d'inclusion
- Multiple myeloma ,Lymphoma, Large B-Cell, Diffuse ,Pleiotropic Pathway Modifier ,Glioblastoma ,LYMPHOMA ,Primary central nervous system lymphoma